The SII CEO said that an emergency approval is awaited from the DGCI for the Oxford-AstraZeneca Covishield vaccine, post which India can start its COVID immunisation program by January 2021 and hope to come back to normalcy by October next year

The Bharat Biotech and Serum Institute vaccine are in their final stage of trials, according to Union Health Minister Dr. Harsh Vardhan who also said that 25-30 crore Indians will be vaccinated by next July-August